Trials / Completed
CompletedNCT02949960
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Dermata Therapeutics · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to evaluate the safety and efficacy of DMT210 Gel, 5% compared to vehicle control following 28 days of twice-daily topical application to selected target lesions in male and female patients with mild to moderate atopic dermatitis (AD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DMT210 Topical Gel | DMT210 Topical Aqueous Gel 5% applied twice daily |
| DRUG | Vehicle Control | Topical Vehicle Gel applied twice daily |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-07-14
- Completion
- 2017-07-14
- First posted
- 2016-10-31
- Last updated
- 2018-04-18
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02949960. Inclusion in this directory is not an endorsement.